| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
11,446 |
9,724 |
$468K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,179 |
2,747 |
$76K |
| 80053 |
Comprehensive metabolic panel |
1,644 |
1,435 |
$12K |
| 80305 |
|
1,567 |
1,362 |
$12K |
| 80061 |
Lipid panel |
1,271 |
1,115 |
$11K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,609 |
1,411 |
$8K |
| 81002 |
|
1,697 |
1,496 |
$3K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
261 |
243 |
$2K |
| 90686 |
|
125 |
109 |
$1K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
67 |
47 |
$1K |
| 90658 |
|
95 |
92 |
$1K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
509 |
407 |
$725.27 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,040 |
1,467 |
$446.54 |
| 90688 |
|
27 |
25 |
$403.75 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
16 |
12 |
$350.95 |
| 87400 |
|
84 |
42 |
$311.09 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
580 |
481 |
$239.33 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
210 |
168 |
$153.08 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
61 |
54 |
$121.81 |
| 85651 |
|
49 |
41 |
$120.47 |
| G0008 |
Administration of influenza virus vaccine |
192 |
147 |
$60.54 |
| 82948 |
|
20 |
19 |
$31.38 |
| Q2039 |
Influenza virus vaccine, not otherwise specified |
15 |
14 |
$25.00 |
| 90694 |
|
153 |
111 |
$25.00 |
| 36415 |
Collection of venous blood by venipuncture |
59 |
55 |
$3.09 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
6,727 |
5,624 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
2,632 |
2,227 |
$0.00 |
| G8783 |
Normal blood pressure reading documented, follow-up not required |
4,327 |
3,670 |
$0.00 |
| G8731 |
Pain assessment using a standardized tool is documented as negative, no follow-up plan required |
190 |
171 |
$0.00 |
| G9744 |
Patient not eligible due to active diagnosis of hypertension |
653 |
555 |
$0.00 |
| G8730 |
Pain assessment documented as positive using a standardized tool and a follow-up plan is documented |
2,705 |
2,258 |
$0.00 |
| 4004F |
|
2,591 |
2,132 |
$0.00 |
| G8482 |
Influenza immunization administered or previously received |
345 |
258 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
1,117 |
994 |
$0.00 |
| G9695 |
Long-acting inhaled bronchodilator prescribed |
360 |
305 |
$0.00 |
| G8753 |
Most recent systolic blood pressure >= 140 mmhg |
668 |
576 |
$0.00 |
| G8598 |
Aspirin or another antiplatelet therapy used |
29 |
26 |
$0.00 |
| 3046F |
|
31 |
28 |
$0.00 |
| G8483 |
Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) |
17 |
15 |
$0.00 |
| 3045F |
|
21 |
14 |
$0.00 |
| G8421 |
Bmi not documented and no reason is given |
14 |
13 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
1,394 |
1,231 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
2,616 |
2,175 |
$0.00 |
| G8755 |
Most recent diastolic blood pressure >= 90 mmhg |
319 |
270 |
$0.00 |
| G9906 |
Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) |
646 |
533 |
$0.00 |
| G9902 |
Patient screened for tobacco use and identified as a tobacco user |
721 |
588 |
$0.00 |
| G8950 |
Elevated or hypertensive blood pressure reading documented, and the indicated follow-up is documented |
440 |
379 |
$0.00 |
| 1036F |
|
1,587 |
1,356 |
$0.00 |
| 3044F |
|
65 |
58 |
$0.00 |
| Q2036 |
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval) |
26 |
25 |
$0.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
370 |
307 |
$0.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
66 |
63 |
$0.00 |
| Q2035 |
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria) |
44 |
44 |
$0.00 |